The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial

Silvia Ponce, Esther Pastor, Belen Orosa, Grace Oscullo, Pablo Catalán, Alfonso Martinez, Luis Hernández, Alfonso Muriel, Eusebi Chiner, Miguel Ángel Martínez-García

Source: Eur Respir J, 54 (2) 1900518; 10.1183/13993003.00518-2019
Journal Issue: August
Disease area: Sleep and breathing disorders

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Silvia Ponce, Esther Pastor, Belen Orosa, Grace Oscullo, Pablo Catalán, Alfonso Martinez, Luis Hernández, Alfonso Muriel, Eusebi Chiner, Miguel Ángel Martínez-García. The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial. Eur Respir J, 54 (2) 1900518; 10.1183/13993003.00518-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of suboptimal adherence of CPAP therapy on symptoms of obstructive sleep apnoea: a randomised, double-blind, controlled trial
Source: Eur Respir J, 55 (3) 1901526; 10.1183/13993003.01526-2019
Year: 2020



Randomized placebo-controlled trial: effects of continuous positive airway pressure in patients with hypertension ²non dipper² without treatment and obstructive sleep apnea
Source: Eur Respir J 2005; 26: Suppl. 49, 723s
Year: 2005

Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study
Source: Eur Respir J 2014; 44: 140-149
Year: 2014



Economic arguments in favor of immediate management of patients with moderate-to-severe obstructive sleep apnea syndrome. A randomised controlled trial
Source: Eur Respir J 2003; 22: Suppl. 45, 353s
Year: 2003

A randomized, double-blind, placebo-controlled trial on the effect of intranasal corticosteroid as a treatment for moderate to severe obstructive sleep apnea with coexisting chronic rhinitis
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019


Treatment of obstructive sleep apnea during decompensations of heart hailure a randomized controlled trial
Source: International Congress 2017 – CPAP therapy
Year: 2017

Effectiveness of non-invasive ventilation in stable chronic obstructive pulmonary disease with nocturnal desaturation: Prospective open-label randomized parallel-group study
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013


Safety and efficacy of sulthiame in moderate to severe obstructive sleep apnea: a randomized placebo-controlled parallel-group trial
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021



Auto-servoventilation in heart failure with sleep apnoea: a randomised controlled trial
Source: Eur Respir J 2013; 42: 1244-1254
Year: 2013



BAY 2253651 for the treatment of obstructive sleep apnoea: a multicentre, double-blind, randomised controlled trial (SANDMAN)
Source: Eur Respir J, 58 (5) 2101937; 10.1183/13993003.01937-2021
Year: 2021



A randomised, double-blind, crossover, placebo-controlled trial of a mandibular advancement device for the treatment of snoring and mild obstructive sleep apnoea-hypopnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 102s
Year: 2002

Randomised controlled trial of the effect of CPAP in uncontrolled nocturnal asthmatic patients with OSAS.
Source: International Congress 2017 – CPAP therapy
Year: 2017


Impact of a multimodal telemonitoring intervention on CPAP adherence in symptomatic low-cardiovascular risk sleep apnea: a randomized controlled trial
Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea
Year: 2020




Effects of CPAP treatment on sex hormone levels in patients with obstructive sleep apnoea - data from two randomized, controlled trials
Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects
Year: 2019




CPAP treatment increases anxiety in coronary artery disease patients with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


A randomized, cross-over, placebo-controlled study of the effects of CPAP upon oxidative stress and nitrate deficiency in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea
Year: 2008

A prospective randomised double-blind placebo controlled trial of venlafaxine in patients with stable chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 32s
Year: 2006

Continuous positive airway pressure effect on visual acuity in patients with type 2 diabetes and obstructive sleep apnoea: a multicentre randomised controlled trial
Source: Eur Respir J, 52 (4) 1801177; 10.1183/13993003.01177-2018
Year: 2018



Impaired control of gait in severe obstructive sleep apnea and continuous positive airway pressure treatment: a randomized controlled trial
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019


Endocrine responses during CPAP-withdrawal in obstructive sleep apnea: data from two randomised controlled trials.
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019